GLP-1 meds (Ozempic, Mounjaro etc.):the PCOS game-changer? скачать в хорошем качестве

GLP-1 meds (Ozempic, Mounjaro etc.):the PCOS game-changer?

Hertility brings you an exclusive Expert Talk with consultant gynaecologist and PCOS expert Dr Paul Hardiman and Dr Helen O’Neill, Hertility founder and Tenured UCL Lecturer in Reproductive and Molecular Genetics, to shed light on endometriosis, one of the most misunderstood and misdiagnosed conditions affecting women's health today. PCOS is one of the most common conditions affecting women’s health,  but research and treatment options remain limited. What progress has been made? And what promising new therapies are on the horizon? In this webinar, Dr Helen O’Neill, Hertility founder and Tenured UCL Lecturer in Reproductive and Molecular Genetics, and Dr Paul Hardiman, Consultant Gynaecologist, UCLH and PCOS expert, will explore the current state of PCOS car and why GLP-1 therapies are emerging as an exciting new avenue. In this Hertility talk, our two experts unpack the latest findings, from symptom management to fertility outcomes, and explore what GLP-1 therapies could mean for the future of care. We discussed: What progress has (and hasn’t) been made in PCOS care and the challenges researchers face Why GLP-1 therapies might be  a promising new treatment What happens when you start, stop, or continue GLP-1 therapy in PCOS This webinar is ideal for anyone experiencing symptoms of PCOS, those diagnosed with the condition, healthcare professionals, and anyone interested in women’s health and fertility. About Dr Paul Hardiman:  Dr Paul Hardiman is a Consultant Gynaecologist and Reader in Reproductive Medicine at University College London Hospitals. He specialises in the management of PCOS, endometriosis, and infertility, with extensive clinical and research expertise in reproductive endocrinology and metabolic health. Dr Hardiman has published widely on PCOS and is actively involved in developing evidence-based approaches to improve outcomes for women with complex reproductive and hormonal conditions. About Dr Helen O'Neill: Dr. Helen O’Neill, BSc (hons), MSc, PhD, Founder and CEO of Hertility, and a Tenured Associate Professor at UCL’s Institute for Women’s Health, specialises in Reproductive and Molecular Genetics. A TEDx speaker and expert in reproductive science, she holds a PhD in Stem Cell Biology and was named among the Top 50 Women in European Tech. About Hertility: ✨ Your journey to understanding your body better starts here! ✨ From hormone testing to fertility insights, we're here to help and can screen for up to 18 conditions like PCOS and endometriosis, all from the comfort of your home! 🩸 Ready to take control of your health? Check out our At-home Hormone & Fertility Test: https://hertilityhealth.com/hormone-a... 📚 Have a browse of our Knowledge Centre for educational blog posts: https://hertilityhealth.com/blog 📱 Find us on socials for more tips, stories, and updates: Instagram:   / hertility   TikTok:   / hertilityhealth   Linkedin:   / hertility   Let’s change the conversation about women’s health together 🫶 #ReproductiveHealth #HormoneHealth #FertilityJourney